Tivantinib added to erlotinib in nonsmallcell lung cancer: The primary end point was not MET...

G. V. Scagliotti, M. Di Maio

Research output: Contribution to journal › Article › peer-review

ASJC Scopus subject areas

@article{48b754d59ecc41ea87013ce3635dcfaf,

title = "Tivantinib added to erlotinib in nonsmallcell lung cancer: The primary end point was not MET...",

author = "Scagliotti, {G. V.} and {Di Maio}, M.",

year = "2015",

month = oct,

day = "1",

doi = "10.1093/annonc/mdv334",

language = "English",

volume = "26",

pages = "2007--2009",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

number = "10",

}

TY - JOUR

T1 - Tivantinib added to erlotinib in nonsmallcell lung cancer

T2 - The primary end point was not MET...

AU - Scagliotti, G. V.

AU - Di Maio, M.

PY - 2015/10/1

Y1 - 2015/10/1

UR - http://www.scopus.com/inward/record.url?scp=84943745810&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943745810&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdv334

DO - 10.1093/annonc/mdv334

M3 - Article

C2 - 26265168

AN - SCOPUS:84943745810

VL - 26

SP - 2007

EP - 2009

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 10

M1 - mdv334

ER -